Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Europe’s opportunity to capture the value in China biotech. McDermott Will & Schulte’s Emmanuelle Trombe and Anthony Paronneau talk to Investors in Healthcare

Analysis Nick Herbert -
China is no longer simply a low-cost engine for biotech development but an increasingly important source of innovation. For European companies and investors, that creates an opportunity to participate in the next stage of Chinese biotech's globalisation. The challenge is working out how to capture the value. A recent roundtable...

Germany: Alantra acts as financial advisor to GPNZ on sale to Mydent

Dental Nick Herbert -
Alantra has acted as exclusive financial advisor to Gesellschaft für Praxisnachfolge in der Zahnmedizin (GPNZ), a network of regional dental practices in Germany, on its sale to Mydent zahnmedizinisches Versorgungszentrum. The combination brings together two established dental groups with complementary regional footprints, creating a network of around 30 locations across Germany. Together, GPNZ and mydent will have greater scale to support the continued development of their practices and services and drive growth. Founded in 2018, GPNZ operates a network of 19 dental clinics, a dental laboratory and a hospital, employing approximately...